Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation

被引：0
|
作者：
LN Türkeri
O Ayaz
M Özyürek
A Akdas
机构：
[1] ‘Ergun Özalp’ Research Laboratory,Department of Urology
[2] Marmara University School of Medicine,undefined
来源：
Prostate Cancer and Prostatic Diseases | 1999年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S33 / S33
相关论文
共 50 条
  • [1] Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation
    Türkeri, LN
    Ayaz, O
    Özyürek, M
    Akdas, A
    PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (Suppl 3) : S33 - S33
  • [2] Oral estramustine and oral etoposide for hormone-refractory prostate cancer
    Dimopoulos, MA
    Panopoulos, C
    Bamia, C
    Deliveliotis, C
    Alivizatos, G
    Pantazopoulos, D
    Constantinidis, C
    Kostakopoulos, A
    Kastriotis, I
    Zervas, A
    Aravntinos, G
    Dimopoulos, C
    UROLOGY, 1997, 50 (05) : 754 - 758
  • [3] Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer
    Pienta, KJ
    Smith, DC
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 72 - 77
  • [4] Augmented cytotoxicity of estramustine in prostate cancer cell lines by N-acetyl-L-cysteine
    Türkeri L.N.
    Özyürek M.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S40 - S40
  • [5] Etoposide and estramustine in previously treated hormone-refractory prostate cancer.
    Pavese, I.
    Di Palma, M.
    Mazzoli, M.
    Burattini, E.
    Satta, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination
    Athanasiadis, A
    Tsavdaridis, D
    Rigatos, SK
    Athanasiadis, I
    Pergantas, N
    Stathopoulos, GP
    ANTICANCER RESEARCH, 2003, 23 (3C) : 3085 - 3088
  • [7] Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer
    Urakami, S
    Igawa, M
    Kikuno, N
    Yoshino, T
    Kishi, H
    Shigeno, K
    Shiina, H
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2444 - 2450
  • [8] A combination vinorelbine-estramustine in patients with hormone refractory prostate cancer
    Butera, A.
    Tornabene, P.
    ANNALS OF ONCOLOGY, 2005, 16 : 82 - 82
  • [9] Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer
    Safarinejad, MR
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (02) : 93 - 101
  • [10] Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer
    Sumiyoshi, Y
    Hashine, K
    Nakatsuzi, H
    Yamashita, Y
    Karashima, T
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (07) : 243 - 247
12345